[{"type": "title", "data": "Acute Coronary Syndrome (ACS) NSTEMI and Unstable Angina - Initial Management"}, {"type": "category", "data": "Admit/Transfer/Discharge"}, {"type": "note", "data": "For ongoing management, please refer to CARD NSTEMI and Unstable Angina - Ongoing Management (Module)", "value": ""}, {"type": "note", "data": "Refer to Non-ST-Elevation Angina Management Algorithm", "value": ""}, {"type": "note", "data": "Calculate GRACE risk score on all NSTEMI patients: GRACE ACS Risk Model Calculator", "value": ""}, {"type": "note", "data": "Calculate Crusade bleeding risk score on all NSTEMI patients: Crusade Bleeding Risk Score Calculator", "value": ""}, {"type": "category", "data": "Medications"}, {"type": "note", "data": "Ensure patient has received a total dose of ASA 160 mg in past 12 hours", "value": ""}, {"type": "order", "data": "ASA chewable", "value": "checked"}, {"type": "sentence", "data": "160 mg, PO, once, drug form: tab-chew, first dose: STAT"}, {"type": "order", "data": "ASA chewable", "value": ""}, {"type": "sentence", "data": "80 mg, PO, once, drug form: tab-chew, first dose: STAT"}, {"type": "note", "data": "Routine pre-treatment with a P2Y12 receptor inhibitor in NSTEMI-ACS patients, in whom an early invasive management is planned and coronary anatomy is not known, is NOT RECOMMENDED given the lack of established benefit. However for patients with a planned delayed invasive management strategy (greater than 24 hours), P2Y12 receptor inhibitor may be considered based on thrombotic and bleed risk; AND likelihood of requiring urgent cardiac surgery in the next 5 days", "value": ""}, {"type": "note", "data": "- For patients requiring long term anticoagulation, clopidogrel is preferred  - Avoid clopidogrel and tricagrelor in patients at high risk for bleeding  - Avoid ticagrelor in patients with severe bradycardia (heart rate less than 50 bpm)  - Hold ticagrelo", "value": ""}, {"type": "order", "data": "ticagrelor", "value": ""}, {"type": "sentence", "data": "180 mg, PO, once, drug form: tab, first dose: STAT"}, {"type": "note", "data": "On ticagrelor in the past consecutive 7 days AND low likelihood of urgent cardiac surgery in the next 5 days", "value": ""}, {"type": "order", "data": "ticagrelor", "value": ""}, {"type": "sentence", "data": "90 mg, PO, once, drug form: tab, first dose: STAT"}, {"type": "note", "data": "Clopidogrel loading dose is only for patients not previously on clopidogrel for past 7 consecutive days  AND low likelihood of urgent cardiac surgery in the next 5 days", "value": ""}, {"type": "note", "data": "Not previously on clopidogrel", "value": ""}, {"type": "order", "data": "clopidogrel", "value": ""}, {"type": "sentence", "data": "300 mg, PO, once, drug form: tab, first dose: STAT"}, {"type": "note", "data": "On clopidogrel in the past consecutive 7 days AND low likelihood of urgent cardiac surgery in the next 5 days", "value": ""}, {"type": "order", "data": "clopidogrel", "value": ""}, {"type": "sentence", "data": "75 mg, PO, once, drug form: tab, first dose: STAT"}, {"type": "note", "data": "Glycoprotein IIb/IIIa Inhibitor (eptifibatide) therapy may be considered in very high risk patients awaiting PCI who have ongoing or recurrent ischemia despite dual antiplatelet therapy and an anticoagulant. Discuss with interventional or local cardiologist prior to ordering", "value": ""}, {"type": "sub phase", "data": "CARD GP llb / llla Inhibitor (eptifibatide) (Module)", "value": ""}, {"type": "note", "data": "No anticoagulation preferred if patient has a known bleeding disorder, or patient has a history of bleeding", "value": ""}, {"type": "order", "data": "Communication Order", "value": ""}, {"type": "sentence", "data": "No anticoagulation preferred, patient has a known bleeding disorder"}, {"type": "order", "data": "Communication Order", "value": ""}, {"type": "sentence", "data": "No anticoagulation preferred,  patient has a history of bleeding"}, {"type": "note", "data": "If anticoagulation required, select heparin OR enoxaparin OR fondaparinux", "value": ""}, {"type": "note", "data": "Heparin infusion is preferred for patients expected to go to the cath lab within 48 hours; or for patients with impaired renal function. Reassess 48 hours after initiation", "value": ""}, {"type": "sub phase", "data": "Heparin Infusion Low PTT Target (Module)", "value": ""}, {"type": "note", "data": "Enoxaparin is INDICATED for patients requiring inter-facility transfer; medically managed patients; low to moderate risk of bleeding", "value": ""}, {"type": "note", "data": "Enoxaparin is CONTRAINDICATED in a patient with a known eGFR of less than 30 mL/min or with suspected severe renal insufficiency. Use with caution and omit IV bolus if age greater than 75 years", "value": ""}, {"type": "order", "data": "enoxaparin", "value": ""}, {"type": "sentence", "data": "1 mg/kg, subcutaneous, q12h, order duration: 8 day, drug form: inj, first dose: STAT"}, {"type": "note", "data": "Fondaparinux is INDICATED for medically managed patients not expected to go to the Cardiac Catheterization lab in the next 7 days; moderate to high risk of bleeding", "value": ""}, {"type": "note", "data": "Fondaparinux is CONTRAINDICATED in a patient with a known eGFR of less than 30 mL/min or with suspected severe renal insufficiency. Not preferred if there is a possibility of PCI within 7 days", "value": ""}, {"type": "order", "data": "fondaparinux", "value": ""}, {"type": "sentence", "data": "2.5 mg, subcutaneous, qPM, order duration: 8 day, drug form: syringe-inj, first dose: STAT"}, {"type": "note", "data": "Avoid nitroglycerin if any of the following are present:  - SBP below 90 mmHg or if more than 30 mmHg drop from baseline  - Suspected right ventricular infarction  - Recent use of phosphodiesterase inhibitors: within 24 hours for sildenafil [VIAGRA] and vardenafil [LEVITRA] and within 48 hours for tadalafil [CIALIS]", "value": ""}, {"type": "order", "data": "nitroglycerin 0.4 mg/spray spray", "value": ""}, {"type": "sentence", "data": "1 spray, sublingual, q5min, PRN pain-chest, drug form: spray"}, {"type": "order", "data": "nitroglycerin titratable infusion (0.2 mg/mL) in D5W standard", "value": ""}, {"type": "sentence", "data": "50 mg"}, {"type": "sentence", "data": "Titrate, IV, 10 mcg/min starting rate, 0 mcg/min minimum rate, 200 mcg/min maximum rate, titrate instructions: Titrate by 10 mcg/min, q5min PRN for symptoms of ischemia; maintain SPB above 90 mmHg"}, {"type": "order", "data": "metoprolol", "value": ""}, {"type": "sentence", "data": "25 mg, PO, BID, drug form: tab, first dose: STAT"}, {"type": "sentence", "data": "12.5 mg, PO, BID, drug form: tab, first dose: STAT"}, {"type": "sentence", "data": "50 mg, PO, BID, drug form: tab, first dose: STAT"}, {"type": "sentence", "data": "100 mg, PO, BID, drug form: tab, first dose: STAT"}, {"type": "order", "data": "morphine PRN range dose", "value": ""}, {"type": "sentence", "data": "dose range: 1 to 5 mg, IV, q1min, PRN other (see comment), drug form: inj"}, {"type": "order", "data": "morphine", "value": ""}, {"type": "sentence", "data": "5 mg, IV, q10min, PRN pain, drug form: inj"}, {"type": "category", "data": "Laboratory"}, {"type": "order", "data": "CBC and Differential", "value": ""}, {"type": "sentence", "data": "Blood, Urgent, Collection: T;N, once"}, {"type": "order", "data": "POC CBC", "value": ""}, {"type": "sentence", "data": "Whole Blood, Urgent, Collection: T;N, once"}, {"type": "order", "data": "POC Hemoglobin", "value": ""}, {"type": "sentence", "data": "once, Urgent"}, {"type": "order", "data": "INR", "value": ""}, {"type": "sentence", "data": "Blood, Urgent, Collection: T;N, once"}, {"type": "order", "data": "POC INR Level", "value": ""}, {"type": "sentence", "data": "once, Urgent"}, {"type": "order", "data": "PTT", "value": ""}, {"type": "sentence", "data": "Blood, Urgent, Collection: T;N, once"}, {"type": "order", "data": "Basic Metabolic Panel (Lytes, Urea, Creat, Gluc)", "value": ""}, {"type": "sentence", "data": "Blood, Urgent, Collection: T;N, once"}, {"type": "order", "data": "POC Basic Metabolic Panel (Lytes, Urea, Creat, Gluc)", "value": ""}, {"type": "sentence", "data": "Whole Blood, Urgent, Collection: T;N, once"}, {"type": "order", "data": "Troponin I Cardiac High Sensitivity", "value": ""}, {"type": "sentence", "data": "Blood, Urgent, Collection: T;N, once"}, {"type": "order", "data": "Troponin I Cardiac High Sensitivity", "value": ""}, {"type": "sentence", "data": "Blood, Timed, Collection: T;N+180, once"}, {"type": "order", "data": "Troponin I Cardiac", "value": ""}, {"type": "sentence", "data": "Blood, Urgent, Collection: T;N, once"}, {"type": "order", "data": "Troponin I Cardiac", "value": ""}, {"type": "sentence", "data": "Blood, Timed, Collection: T;N+180, once"}, {"type": "order", "data": "POC Troponin I", "value": ""}, {"type": "sentence", "data": "Whole Blood, Urgent, Collection: T;N, once"}, {"type": "order", "data": "POC Troponin I", "value": ""}, {"type": "sentence", "data": "Whole Blood, Timed, Collection: T;N+180, once"}, {"type": "order", "data": "Troponin T Cardiac High Sensitivity", "value": ""}, {"type": "sentence", "data": "Blood, Urgent, Collection: T;N, once"}, {"type": "order", "data": "Troponin T Cardiac High Sensitivity", "value": ""}, {"type": "sentence", "data": "Blood, Timed, Collection: T;N+180, once"}, {"type": "order", "data": "Urinalysis Macroscopic (dipstick) with Microscopic if indicated", "value": "checked"}, {"type": "sentence", "data": "Urine, Urgent, Collection: T;N, once"}, {"type": "order", "data": "HIV 1/2 Antibody and p24 Antigen BCCDC", "value": ""}, {"type": "sentence", "data": "Blood, Urgent, Collection: T;N, once"}, {"type": "order", "data": "HIV 1/2 Antibody and p24 Antigen PHC", "value": ""}, {"type": "sentence", "data": "Blood, Urgent, Collection: T;N, once"}, {"type": "category", "data": "Consults/Referrals"}, {"type": "order", "data": "ED Consult to Cardiology", "value": ""}, {"type": "sentence", "data": "Urgent"}, {"type": "order", "data": "ED Consult to General Internal Medicine", "value": ""}, {"type": "sentence", "data": "Urgent"}, {"type": "order", "data": "ED Consult to Hospitalist Medicine", "value": ""}, {"type": "sentence", "data": "Urgent"}, {"type": "order", "data": "ED Consult to AIMS", "value": ""}, {"type": "sentence", "data": "Urgent"}, {"type": "note", "data": "Consider consultation with Patient Transfer Network", "value": ""}]
